Авторы

  • Ашуров Ш.В., Олимова А.З.

Ключевые слова:

хроническая болезнь почек, бедренная кость, ренальная остеодистрофия, CKD-MBD, костное ремоделирование, остеобласты, остеокласты, FGF23, Klotho, PTH, RANKL, Wnt, склеростин, гистоморфометрия.

Библиографические ссылки

1. Moe, S. M., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006). Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 69 (11), 1945–1953. https://doi.org/10.1038/sj.ki.50 00414

2. Drüeke, T. B., & Massy, Z. A. (2016). Changing bone patterns with progression of chronic kidney disease. Kidney International, 89(2), 289–302. https://doi.org/10.1016/j.kint.2015.12.004

3. Zheng, C. M., Zheng, J. Q., Wu, C. C., Lu, C. L., Shyu, J. F., Hsu, Y. H., Wu, M. Y., Chiu, I. J., Wang, Y. H., Lin, Y. F., & Lu, K. C. (2016). Bone loss in chronic kidney disease: Quantity or quality? Bone, 87, 57–70. https://doi.org/10.1016/j.bone.2016.03.017

4. McNerny, E. M. B., & Nickolas, T. L. (2017). Bone quality in chronic kidney disease: Definitions and diagnostics. Current Osteoporosis Reports, 15(3), 207–213. https://doi.org/10.1007/s11914-017-03 66-z

5. Carrillo-López, N., Panizo, S., Alonso-Montes, C., Román-García, P., Rodríguez, I., Martínez-Salgado, C., Dusso, A. S., Naves, M., & Cannata-Andía, J. B. (2016). Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney International, 90(1), 77–89. https://doi.org/10.1016/j.kint. 2016.01.024

6. Komaba, H., & Lanske, B. (2018). Role of Klotho in bone and implication for CKD. Current Opinion in Nephrology and Hypertension, 27(4), 298–304. https://doi.org/10.1097/MNH.000000000000 0423

7. Bucur, R. C., Panjwani, D. D., Turner, L., Rader, T., West, S. L., & Jamal, S. A. (2015). Low bone mineral density and fractures in stages 3–5 CKD: An updated systematic review and meta-analysis. Osteoporosis International, 26(2), 449–458. https://doi. org/10.1007/s00198-014-2813-3

8. Ni, L. H., Tang, R. N., Lv, L. L., Wu, M., Wang, B., Wang, F. M., Ni, H. F., Song, K. Y., Wang, L. T., Zou, M., Chen, Q., & Liu, B. C. (2018). A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. Biochemical and Biophysical Research Communications, 498(3), 654–659. https://doi.org/10.1016/j.bbrc.2018.03.038

9. Claramunt, D., Gil-Peña, H., Fuente, R., García-López, E., Loredo, V., Hernández-Frías, O., Ordoñez, F. A., Rodríguez-Suárez, J., & Santos, F. (2015). Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia. American Journal of Physiology-Renal Physiology, 309(1), F57–F62. https://doi.org/10.1152/ajprenal. 00051.2015

10. Saito, H., Miyakoshi, N., Kasukawa, Y., Nozaka, K., Tsuchie, H., Sato, C., Abe, K., Shoji, R., & Shimada, Y. (2021). Analysis of bone in adenine-induced chronic kidney disease model rats. Osteoporosis and Sarcopenia, 7(4), 121–126. https://doi.org/ 10.1016/j.afos.2021.11.001

11. Lehmann, G., Ott, U., Kaemmerer, D., Schuetze, J., & Wolf, G. (2008). Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3–5. Clinical Nephrology, 70(4), 296–305. https://doi.org/10. 5414/CNP70296

12. Ferreira, A. C., Cohen-Solal, M., D’Haese, P. C., & Ferreira, A. (2021). The role of bone biopsy in the management of CKD-MBD. Calcified Tissue International, 108(4), 528–538. https://doi.org/10.1007/ s00223-021-00838-z

13. Jørgensen, H. S., Behets, G., Viaene, L., Bammens, B., Claes, K., Meijers, B., Naesens, M., Sprangers, B., Kuypers, D., D’Haese, P. C., & Evenepoel, P. (2021). Static histomorphometry allows for a diagnosis of bone turnover in renal osteodystrophy in the absence of tetracycline labels. Bone, 152, 116066. https://doi.org/10.1016/j.bone.2021.116066

14. Jørgensen, H. S., Ferreira, A. C., D’Haese, P., Haarhaus, M., Vervloet, M., Lafage-Proust, M.-H., Ferreira, A., & Evenepoel, P. (2022). Bone histomorphometry for the diagnosis of renal osteodystrophy: A call for harmonization of reference ranges. Kidney International, 102(2), 431–434. https://doi.org/10. 1016/j.kint.2022.04.030

15. Aguilar, A., Gifre, L., Ureña-Torres, P., Carrillo-López, N., Rodriguez-García, M., Massó, E., da Silva, I., López-Báez, V., Sánchez-Bayá, M., Prior-Español, Á., Urrutia, M., Paul, J., Bustos, M. C., Vila, A., Garnica-León, I., Navarro-González, J. F., Mateo, L., & Bover, J. (2023). Pathophysiology of bone disease in chronic kidney disease: From basics to renal osteodystrophy and osteoporosis. Frontiers in Physiology, 14, 1177829. https://doi.org/10.3389/fphys.2023. 1177829

16. Williams, M. J., White, S. C., Joseph, Z., & Hruska, K. A. (2023). Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-vascular paradox, a therapeutic target, and a biomarker. Frontiers in Physiology, 14, 1120308. https: //doi.org/10.3389/fphys.2023.1120308

17. Suzuki, K., Soeda, K., & Komaba, H. (2024). Crosstalk between kidney and bone: Insights from CKD-MBD. Journal of Bone and Mineral Metabolism, 42(4), 463–469. https://doi.org/10.1007/s00774-024-01528-0

18. Metzger, C. E., Kittaka, M., LaPlant, A. N., Ueki, Y., & Allen, M. R. (2024). Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice. JBMR Plus, 8(2), ziae004. https://doi.org/10.1093/jbmrpl/ziae004

19. Gupta, S., Portales-Castillo, I., Daher, A., & Kitchlu, A. (2021). Conventional chemotherapy nephrotoxicity. Advances in Chronic Kidney Disease, 28(5), 402–414.e1. https://doi.org/10.1053/j.ackd. 2021.08.001

20. Lafage-Proust, M.-H., Jørgensen, H. S., Bravenboer, N., Ferreira, A., Bégin, M.-J., Cannata-Andía, J., Cejka, D., Chavassieux, P., Cohen-Solal, M., D’Haese, P., Fahrleitner-Pammer, A., Ferreira, A. C., Fusaro, M., Gerbaix, M., Hamdy, N., Hansen, D., de Jongh, R., Kröger, H., Lalayiannis, A. D., … Evenepoel, P. (2025). Bone histomorphometry for the diagnosis of renal osteodystrophy: A European consensus statement. Bone, 199, 117544. https://doi.org/10.1016/j.bone. 2025.117544